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Ventilator-associated pneumonia (VAP) refers to inflammation of the lung 
parenchyma caused by an infectious agent acquired during invasive mechanical 
ventilation. The criteria used to define VAP are the subject of ongoing controversy 
and there remains no universally agreed international definition, at least in part 
accounting for the wide range of reported incidence [1]. Despite this, surveillance and 
public reporting for VAP is advocated by legislatures, accreditation agencies, and 
consumer organizations because it is viewed as a preventable complication with 
attributable morbidity and mortality [2].  
 
In Europe the European Centre for Disease Control (ECDC) definitions are used [3]. 
Subjective chest x-ray interpretation and pulmonary symptoms are combined with 
objective systemic features of infection with or without supporting microbiological 
data (supplemental table 1). In contrast, the Centre for Disease Control (CDC) in the 
USA employs an algorithm designed to be entirely objective, developed and 
extensively evaluated with the aim of decreasing variation attributable to subjective 
interpretation [4]. It returns a hierarchical diagnosis culminating in probable VAP, 
triggered by a sustained deterioration in oxygenation after stability plus objective 
systemic features with mandatory supportive microbiology (supplemental table 2). 
We carried out a 12-month regional comparison of the surveillance definitions and 
posed the following research questions: what is the incidence of VAP when 
ascertained by ECDC or CDC definitions and what is the concordance between 
ECDC and CDC surveillance definitions?   
 
We performed an observational study of all consecutive admissions to two large adult 
intensive care units in Edinburgh, UK. The data protection guardian approved the 
study; as a service evaluation ethics committee approval was not required. Two 
independent teams carried out each surveillance algorithm separately (more 
information available in the supplemental material). Concordant events between 
different algorithms were defined as those occurring not more than two calendar days 
either side of the day of diagnosis. Concordance was quantified using Cohen’s kappa.   
 
Between 1st June 2015 and 31st May 2016, we enrolled 1,240 sequential admissions 
who stayed longer than two calendar days. 713 (57.5%) were mechanically ventilated 
for more than two calendar days and formed our at-risk population for VAP as well as 
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providing the denominator for total ventilation days. Overall, the VAP rates per 1000 
ventilation days (±95% confidence interval) were very similar (ECDC 5.4 (3.8-7.5), 
CDC 4.6 (3.1-6.6)). However, events diagnosed as VAP with the two surveillance 
definitions were almost completely discordant (Cohen’s kappa 0.082 (95% CI: -0.034 
to 0.191)). Reasons for discordance are shown in figure 1. 
 
The recommended methods for VAP surveillance in Europe (ECDC) and the US 
(CDC) use different case definitions to identify VAP for surveillance to inform 
quality improvement and infection prevention. They report similar population-level 
rates of VAP but with almost no concordance among VAP events, predominantly due 
to either the absence of a sustained deterioration in oxygenation after stability or 
absence of relevant x-ray changes. These data suggest caution in comparing rates 
reported using different surveillance systems, and remind us these definitions should 
not be used to identify true VAP events in individual patients. 
 
 
 
Figure 1 – Examination of discordance between surveillance definitions.  
Flow chart illustrates each permutation of surveillance with ECDC and CDC systems 
with total number of patients (%). If a VAP event was triggered by one definition, the 
absence of a VAP event defined using the other definition within a five-day window 
centered on the trigger date was defined as discordance. Inset graphs: Top bar – 
proportion of events where the attending clinician initiated a course of antibiotics to 
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treat suspected VAP. Bottom bar – Reasons for not progressing to VAP via the 
alternate surveillance definition. Bars refer only to events within five-day window of 
VAP trigger date. VAC – ventilator-associated complication, PVAP – probable 
ventilator-associated pneumonia. 
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